ACST 3.33 Acasti Pharma Inc.
| Range: | 1.98-3.59 | Vol Avg: | 22070 | Last Div: | 0 | Changes: | -0.01 |
| Beta: | 1.52 | Cap: | 0.03B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Tue Feb 07 2012 | Empoloyees: | 32 | ||
| CUSIP: | 00430K402 | CIK: | 0001444192 | ISIN: | CA00430K8656 | Country: | CA |
| CEO: | Mr. Prashant Kohli | Website: | https://www.acastipharma.com | ||||
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow